Form 4: Hims & Hers CFO Sells Shares Under 10b5-1 Plan

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, sold 23,090 shares of Class A Common Stock for an average price of $35.7172 per share.

Summary

• Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), disposed of 23,090 shares of Class A Common Stock.
• The transaction occurred on December 22, 2025, at an average weighted price of $35.7172 per share.
• The shares were sold at varying prices ranging from $35.36 to $35.88.
• This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Okupe on May 21, 2025.
• Following the transaction, Mr. Okupe directly beneficially owns 94,333 shares of Class A Common Stock.
• Additionally, Mr. Okupe indirectly beneficially owns 7,853 shares held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-established 10b5-1 trading plan, which is a neutral event for company operations and does not inherently signal a change in company fundamentals.

Negatives

• An insider sale, even under a 10b5-1 plan, can sometimes be perceived negatively by investors, potentially signaling a lack of confidence, although this is often a pre-planned diversification or liquidity event.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders will note the Chief Financial Officer's sale of shares, which is a standard disclosure for insider transactions.

Key Dates

Recommendation

The filing details a pre-scheduled insider stock sale by the CFO, which is a routine event and does not inherently signal a change in the company's fundamental outlook or warrant an immediate change in investment strategy based solely on this disclosure. Investors should consider broader company performance and market conditions.

Keywords

Hims & Hers, HIMS, Oluyemi Okupe, CFO, Insider Trading, Stock Sale, Form 4, 10b5-1 Plan, Equity Disposal